Low levels of PSMA expression limit the utility of 18F-DCFPyL PET/CT for imaging urothelial carcinoma

Authors:

Abstract
To explore the clinical utility of PSMA-targeted 18F-DCFPyL PET/CT in patients with metastatic urothelial carcinoma.
Funding Information
  • National Institutes of Health (CA134675, CA183031)

This publication has 32 references indexed in Scilit: